306 related articles for article (PubMed ID: 22468682)
1. Periodontal status and hyperlipidemia: statin users versus non-users.
Sangwan A; Tewari S; Singh H; Sharma RK; Narula SC
J Periodontol; 2013 Jan; 84(1):3-12. PubMed ID: 22468682
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of periodontal status in subjects with hyperlipidemia.
Awartani F; Atassi F
J Contemp Dent Pract; 2010 Mar; 11(2):033-40. PubMed ID: 20228985
[TBL] [Abstract][Full Text] [Related]
3. Association of serum lipid indices and statin consumption with periodontal status.
Sayar F; Fallah S; Akhondi N; Jamshidi S
Oral Dis; 2016 Nov; 22(8):775-780. PubMed ID: 27426870
[TBL] [Abstract][Full Text] [Related]
4. Short-term effects of periodontal therapy as an adjunct to anti-lipemic treatment.
Fentoğlu O; Sözen T; Oz SG; Kale B; Sönmez Y; Tonguç MO; Gürgan CA; Aykaç Y; Kirzioğlu FY
Oral Dis; 2010 Oct; 16(7):648-54. PubMed ID: 20412449
[TBL] [Abstract][Full Text] [Related]
5. Periodontal status in subjects with hyperlipidemia and determination of association between hyperlipidemia and periodontal health: a clinicobiochemical study.
Shivakumar T; Patil VA; Desai MH
J Contemp Dent Pract; 2013 Sep; 14(5):785-9. PubMed ID: 24685775
[TBL] [Abstract][Full Text] [Related]
6. Serum lipoprotein-associated phospholipase A₂ and C-reactive protein levels in association with periodontal disease and hyperlipidemia.
Fentoğlu O; Köroğlu BK; Kara Y; Doğan B; Yılmaz G; Sütçü R; Ay ZY; Tonguç MÖ; Orhan H; Tamer MN; Kırzıoğlu FY
J Periodontol; 2011 Mar; 82(3):350-9. PubMed ID: 20809860
[TBL] [Abstract][Full Text] [Related]
7. Clinical periodontal and microbiologic parameters in patients with acute myocardial infarction.
Stein JM; Kuch B; Conrads G; Fickl S; Chrobot J; Schulz S; Ocklenburg C; Smeets R
J Periodontol; 2009 Oct; 80(10):1581-9. PubMed ID: 19792846
[TBL] [Abstract][Full Text] [Related]
8. Periodontal status in subjects with hyperlipidemia.
Fentoğlu O; Oz G; Taşdelen P; Uskun E; Aykaç Y; Bozkurt FY
J Periodontol; 2009 Feb; 80(2):267-73. PubMed ID: 19186967
[TBL] [Abstract][Full Text] [Related]
9. Association of simvastatin and hyperlipidemia with periodontal status and bone metabolism markers.
Magán-Fernández A; Papay-Ramírez L; Tomás J; Marfil-Álvarez R; Rizzo M; Bravo M; Mesa F
J Periodontol; 2014 Oct; 85(10):1408-15. PubMed ID: 24555750
[TBL] [Abstract][Full Text] [Related]
10. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
[TBL] [Abstract][Full Text] [Related]
11. Impact of fluvastatin on hyperlipidemia after renal transplantation.
Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
[TBL] [Abstract][Full Text] [Related]
12. Serum plasminogen activator inhibitor-1 and tumor necrosis factor-α levels in obesity and periodontal disease.
Akman PT; Fentoğlu O; Yılmaz G; Arpak N
J Periodontol; 2012 Aug; 83(8):1057-62. PubMed ID: 22141357
[TBL] [Abstract][Full Text] [Related]
13. Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: a randomized, placebo-controlled study.
Schrott HG; Knapp H; Davila M; Shurzinske L; Black D
Am Heart J; 2000 Aug; 140(2):249-52. PubMed ID: 10925339
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation.
Demetriou D; Shabpar A; Böhmig G; Schmaldienst S; Hörl WH; Watschinger B
Wien Klin Wochenschr; 2000 Apr; 112(8):358-61. PubMed ID: 10849941
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokine levels in hyperlipidemic patients with periodontitis after periodontal treatment.
Fentoğlu O; Kirzioğlu FY; Ozdem M; Koçak H; Sütçü R; Sert T
Oral Dis; 2012 Apr; 18(3):299-306. PubMed ID: 22151458
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.
Soran H; France MW; Kwok S; Dissanayake S; Charlton-Menys V; Younis NN; Durrington PN
Ann Clin Biochem; 2011 Nov; 48(Pt 6):566-71. PubMed ID: 22006975
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients.
Kanbay M; Yildirir A; Bozbas H; Ulus T; Bilgi M; Muderrisoglu H; Akcay A; Ozdemir FN
Ren Fail; 2005; 27(3):297-303. PubMed ID: 15957546
[TBL] [Abstract][Full Text] [Related]
19. Changes in inflammatory and metabolic parameters after periodontal treatment in patients with and without obesity.
Altay U; Gürgan CA; Ağbaht K
J Periodontol; 2013 Jan; 84(1):13-23. PubMed ID: 22348694
[TBL] [Abstract][Full Text] [Related]
20. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
